ing cyclosporin A were used to measure whole-blood concentrations of the immunosuppressant cyclosporin G (CsG) in renal transplant patients. We performed a threeway comparison of these two immunoassays and HPLC. Although the two immunoassays agreed favorably, both the monoclonal fluorescence polarization immunoassay and the monoclonal RIA yielded higher CsG results for patients' specimens than did the liquid-chromatographic assay. The experimental data indicate that the observed differences are most likely due to the cross-reactivity of CsG metabolites in the immunoassays. Despite the potent immunosuppressive properties of the drug, the clinical use of CsA is complicated by several negative side effects, primary among these being renal dysfunction. Over the last several years, other CsA analogs that may be useful as immunosuppressants have received attention. One of these candidates is the compound cyclosporun G (OG 37-325; CsG), a structural analog of CsA, in which norvaline is substituted for a-aminobutyric acid in position 2. Studies on urine samples show that CsG is metabolized via hydroxylation and demethylation, as is CsA (13). CsG is as potent as CsA in preventing allograft rejection in several animal models, but reportedly does not produce the reduced renal function observed with the use of CsA.
blood be used as the specimen of choice and also that the analytical methods used to monitor CsA in blood be specific for the parent compound. The proposed reference method, which is used in many clinical laboratories for quanti1ying CsA, has been HPLC. Although HPLC is the most selective method and satisfies the consensus recommendations for therapeutic drug monitoring, the highly technical nature and potentially slow turnaround time eliminate HPLC as a usable analytical method in some institutions.
The Specimens that were transported from one evaluation site to another were portioned into 1.5-mL polypropylene tubes, sealed with an 0-ring fitted cap, and kept in short-term storage at -20 #{176}C before transport by overnight delivery. To assure specimen integrity during storage, we reanalyzed by HPLC multiple specimens that had been stored frozen for several months and found no change in concentration of CsG.
Materials and Methods

Patients
Immunoassays.
The two immunoassays evaluated in the present study were the CYCLO-Trac SP whole-blood monoclonal-based RIA kit ( calibration assignments. As shown in 
